AR022404A1 - METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY - Google Patents

METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY

Info

Publication number
AR022404A1
AR022404A1 ARP000100289A ARP000100289A AR022404A1 AR 022404 A1 AR022404 A1 AR 022404A1 AR P000100289 A ARP000100289 A AR P000100289A AR P000100289 A ARP000100289 A AR P000100289A AR 022404 A1 AR022404 A1 AR 022404A1
Authority
AR
Argentina
Prior art keywords
tissue
agents
radiation therapy
volume
improved radiation
Prior art date
Application number
ARP000100289A
Other languages
Spanish (es)
Original Assignee
Photogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photogen Inc filed Critical Photogen Inc
Publication of AR022404A1 publication Critical patent/AR022404A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Método para tratar un volumen seleccionado de tejido, método que incluye la distribucion de un radiosensibilizante y una pluralidad de fuentes deradiacion ionizantes sustancialmente dentro del volumen de tejido para producir zonas de tratamiento queestán, en general, uniformemente distribuidas por todoel volumen del tejido. También se incluye un agente para tratar dicho tejido, agente que incluye un radiosensibilizante y una fuente de radiacion ionizanteempleados conjuntamente para definir una gente de tratamiento inyectable.Method for treating a selected volume of tissue, a method that includes the distribution of a radiosensitizer and a plurality of ionizing radiation sources substantially within the volume of tissue to produce treatment areas that are generally uniformly distributed throughout the volume of the tissue. Also included is an agent for treating said tissue, an agent that includes a radiosensitizer and a source of ionizing radiation employed together to define an injectable treatment people.

ARP000100289A 1999-01-25 2000-01-24 METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY AR022404A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23624799A 1999-01-25 1999-01-25

Publications (1)

Publication Number Publication Date
AR022404A1 true AR022404A1 (en) 2002-09-04

Family

ID=22888723

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100289A AR022404A1 (en) 1999-01-25 2000-01-24 METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY

Country Status (10)

Country Link
EP (1) EP1146912A4 (en)
JP (1) JP2002535291A (en)
KR (1) KR20020001723A (en)
CN (1) CN1337886A (en)
AR (1) AR022404A1 (en)
AU (1) AU2972500A (en)
BR (1) BR0007692A (en)
CA (1) CA2358989A1 (en)
IL (1) IL144428A0 (en)
WO (1) WO2000043045A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348536A1 (en) * 1998-10-29 2000-05-11 The General Hospital Corporation Radiodense compositions
US8470296B2 (en) 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US20020001567A1 (en) 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
CN1205999C (en) * 1999-02-08 2005-06-15 阿尔萨公司 Liposone composition and method for administration of a radiosensitizer
US6818227B1 (en) 1999-02-08 2004-11-16 Alza Corporation Liposome composition and method for administration of a radiosensitizer
WO2001008660A2 (en) * 1999-08-02 2001-02-08 The Regents Of The University Of Michigan Targeted fiberless radiative effectors
US7776310B2 (en) 2000-11-16 2010-08-17 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US6746661B2 (en) 2000-11-16 2004-06-08 Microspherix Llc Brachytherapy seed
WO2002068000A2 (en) * 2000-11-16 2002-09-06 Microspherix Llc Polymeric imagable brachytherapy seed
BRPI0417517A (en) * 2003-12-11 2007-03-06 Schering Ag method for improving efficacy of therapeutic radiolabelled drugs
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
US8252756B2 (en) 2005-06-14 2012-08-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
MX2009008470A (en) 2007-02-09 2009-11-26 Univ Northwestern Particles for detecting intracellular targets.
AU2008259907B2 (en) 2007-05-30 2014-12-04 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
KR101525132B1 (en) * 2008-10-08 2015-06-02 포항공과대학교 산학협력단 Capsule of x-ray contrast agent and preparing method thereof
AU2009316286B2 (en) 2008-11-24 2016-05-26 Northwestern University Polyvalent RNA-nanoparticle compositions
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
US8269197B2 (en) 2009-07-22 2012-09-18 Intraop Medical Corporation Method and system for electron beam applications
US20120277283A1 (en) * 2009-08-04 2012-11-01 Mirkin Chad A Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
CN102666879B (en) 2009-10-30 2016-02-24 西北大学 Templated nanometer conjugate
CN102933258A (en) 2010-03-01 2013-02-13 因特奥普医药公司 Radiotherapy combined with hypoxic cell sensitizers
AU2012308302A1 (en) 2011-09-14 2014-03-20 Northwestern University Nanoconjugates able to cross the blood-brain barrier
US10894963B2 (en) 2013-07-25 2021-01-19 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
JP2017537619A (en) 2014-11-21 2017-12-21 ノースウェスタン ユニバーシティ Sequence-specific intracellular uptake of spherical nucleic acid nanoparticle complexes
WO2016148969A1 (en) * 2015-03-13 2016-09-22 The Board Of Regents Of The University Of Texas System Kub5/hera as a determinant of sensitivity to dna damage
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490543A (en) * 1982-11-12 1984-12-25 University Of Northern Iowa Foundation Low toxicity radiation sensitizer
US5342283A (en) * 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
US6331286B1 (en) * 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions

Also Published As

Publication number Publication date
CA2358989A1 (en) 2000-07-27
JP2002535291A (en) 2002-10-22
WO2000043045A1 (en) 2000-07-27
KR20020001723A (en) 2002-01-09
IL144428A0 (en) 2002-05-23
AU2972500A (en) 2000-08-07
EP1146912A4 (en) 2003-05-21
BR0007692A (en) 2001-11-06
EP1146912A1 (en) 2001-10-24
CN1337886A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
AR022404A1 (en) METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY
AR021967A1 (en) HIGH ENERGY PHOTOTHERAPEUTIC AGENTS
BR9712599A (en) Processes for the treatment of a particular volume, of cancer and of a volume of cancerous tissue in tissue and for producing at least one photo-active molecular agent in a particular volume of material and apparatus for the treatment of a particular volume of plant tissue or of animals and for the administration of a photo-dynamic medical treatment
ES2179096T3 (en) USE OF INTERLEUCINE-12 TO PREVENT REACTION OF THE GRAFT AGAINST THE GUEST.
BR9911161A (en) Processes for treating a particular volume of plant or animal tissue, for producing at least one photoactivated agent in a particular volume of material, for the medical treatment of a particular volume of tissue, and apparatus for treating a volume plant or animal tissue and, for the administration of a photodynamic medical treatment.
AR021061A1 (en) METHOD FOR PRODUCING IMPROVED IMAGES AND PHOTODYNAMIC THERAPY
HK1050847A1 (en) Treatment of congestive heart failure by pretreated autologous blood.
AR010259A1 (en) A TREATMENT PROCESS FOR CELLULOSIC FIBERS AND THE MATRIX OBTAINED
ES2064121T3 (en) AGENT TO REDUCE OR ELIMINATE THE GROWTH OF HAIR IN THE HUMAN BODY.
EP1628667A4 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antimitotics
EA200101089A1 (en) NEW METHOD OF TREATMENT
ES2139002T3 (en) CYTOTOXIC DRUG THERAPY.
EP1631267A4 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites
AR037346A1 (en) COMBINATION THERAPY
AR004494A1 (en) A CELL USEFUL FOR THE TREATMENT OF PAIN, A METHOD TO PRODUCE IT, A BIOARTIFICIAL ORGAN OF UNDERSTAND IT AND A METHOD TO PREPARE SUCH ORGANOBIOARTIFICIAL
DK1077683T3 (en) Antidepressant treatment
MX2022001450A (en) Method of treating cancer.
MD106C2 (en) Method of treatment for mamma cancer
MX9206135A (en) METHODS
NO984189L (en) Procedure for the treatment of bipolar disorder
ES2152664T3 (en) COMBINATION OF CIS-4-HYDROXY-L-PROLIN AND N-METHYL-C-4-HYDROXY-L-PROLIN FOR APPLICATION AS A THERAPEUTIC AGENT, ESPECIALLY FOR THE TREATMENT AGAINST CANCER.
ATE306278T1 (en) TREATING BONE DISEASES WITH ADRENOMEDULLIN
MX9304878A (en) USE OF A SUBSTITUTED AZASPIRAN IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF PSORIASIS.
RU94024337A (en) Antimetastatic agent
ECSP951438A (en) Azithromycin Controlled Release Dosage Forms